United States

Ambrx Biopharma is a clinical-stage biologics company that develops precision biologics using its proprietary expanded genetic code technology platform. Its lead product candidate is ARX788, an anti-HER2 antibody-drug conjugate for the treatment of breast cancer and other solid tumors. The company is also developing two earlier-stage product candidates and multiple product candidates targeting immuno-oncology applications. Ambrx Biopharma has collaborations with several companies and is headquartered in La Jolla, California.

Google

Termékmenedzser

Adattudós

Ambrx

Ambrx Nyitott Állások

Készen áll karrierje következő szintjére? Tekintse meg ezeket a nyitott pozíciókat a(z) Ambrx cégnél.